The cost of Revlimid can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Revlimid. As with all ...

Bristol-Myers Squibb's blood cancer blockbuster Revlimid is finally facing generic competition in the US, which will eat into revenues from a drug that made a massive $12.8 billion in sales last year.

NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.